6
Oct
2026

Zhejiang Supor Pharmaceuticals Co. Ltd

Exhibitor at CPHI Milan 2026 stand 2A104, API
About Us

Supor Pharma is specialized in manufacturing of APIs, the facility has been approved by US FDA , EU EDQM , SFDA and other national authorities for several times. We supplied our products widely to domestic market and foreign market. All the commercial products are with DMF and we are experienced in  registration in global markets.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Primary activities
Generic APIs producer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 2A104, API

Products Featured at CPHI Milan 2026

  • quetiapine fumarate

    Product quetiapine fumarate

    This product is with US FDA and EU EDQM approvals, CEP, DMF, GMP and other international certificates are available.
  • bupropion HCL

    Product bupropion HCL

    This product has passed US FDA inspection, the DMF and other international certificates are available.
  • felodipine

    Product felodipine

    The product has been approved by US FDA, CEP DMF and GMP are available.
  • Tinidazole

    Product Tinidazole

    The product has been approved by US FDA and EU EDQM, local GMP , EU  GMP, CEP and DMF are available.
  • olanzapine

    Product olanzapine

    Zhejiang Supor Pharmaceuticals Co. Ltd offers a wide range of products which includes olanzapine. It belongs to API category. Contact us for more information.